262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study
Title:
262MO Preliminary efficacy outcomes of ivosidenib in patients with IDH1-mutated cholangiocarcinoma (mIDH1 CCA): Initial results from the phase IIIb ProvIDHe study
Author:
Bridgewater, J.A. Gardini, A. Casadei Wilmink, H. Mercade, T. Macarulla Sim, H-W. Verslype, C. Roderburg, C. Touchefeu, Y. McDermott, R.S. Kordes, M. Lee, C-K. Vogel, A. Kzhdryan, H.G.K. Vidra, R.A. Rumpold, H. Sullivan, A. Gharbi, H. Minguez, V. Manuel Robert, R. Rimassa, L.